LeoneADe AmicisRLessaCTagliabueATrentaniCFerrarisCet al
This guide breaks down what the current research says about BPC-157 and TB-500, how their mechanisms differ, and where each one shows the most research interest
21, 2025, the FDA determined that the semaglutide shortage is over, giving compounding pharmacies a deadline for ceasing the distribution of compounded versions of injectable semaglutide that are essentially identical to FDA-approved versions (e.g., Wegovy and Rybelsus)
Patients who want only the sexual health benefit with no tanning effect, or who have any dermatological concern about MC1R activation, are better served by PT-141
Educational leadership since 2012 A founder-led team collaborating with clinicians, researchers, and health writers to make complex science accessible and actionable
Snacks that pack electrolyte value When you can only manage a few bites between meals, make those bites count